OBJECTIVE: To measure prevalence of syphilis among the STI clinic population in Guangxi, China, and to assess the socioeconomic and behavioural characteristics associated with the infection. METHODS: We undertook a cross-sectional survey and syphilis and HIV serologic testing among 11 473 patients attending 14 community and hospital-based dermatovenereal clinics across eight cities in Guangxi between December 2004 and February 2006. RESULTS: 1297 (11.9%) patients demonstrated positive toludine red unheated serum test and Treponema pallidum particle agglutination results with serologic testing. A total of 58% (752) of seropositive subjects presented with a genital ulcer, palmar/plantar rash or inguinal lymphadenopathy. Female sex (OR = 2.23, 95% confidence intervals (CI) = 1.69 to 3.00, p<0.001), less education (middle school, OR = 1.70, 95% CI = 1.11 to 2.62, p = 0.023; primary school or less, OR = 1.98, 95% CI = 1.13 to 3.46, p = 0.017) and high annual income (OR = 1.91, 95% CI = 1.18 to 3.10, p = 0.009 for >30 000 RMB yuan) were associated with serologically positive status. Syphilis infection was significantly more prevalent in city 2 (19.5%, OR = 3.07, 95% CI = 1.83 to 5.16, p<0.001), city 4 (16.6%, OR = 1.90, 95% CI = 1.10 to 3.28, p = 0.011) and city 8 (13.8%, OR = 1.83, 95% CI = 1.13 to 2.97, p = 0.006). A total of 40.1% (532) of infected subjects engaged in commercial sex and increased rates of the infection was associated with multiple sexual partners (OR = 1.54, 95% CI = 1.16 to 2.06, p = 0.003). A total of 1.2% (133) of participants carried laboratory markers for HIV and 1.8% (23) of patients with syphilis were positive for HIV. CONCLUSIONS: Syphilis infection has reached alarming rates in China's STI clinic population, suggesting a generalised spread of the disease through commercial sex and bridging populations. Syphilis control is deserving of China's highest priority. Universal screening for syphilis and HIV testing in STI clinics should be considered as measures for control.
OBJECTIVE: To measure prevalence of syphilis among the STI clinic population in Guangxi, China, and to assess the socioeconomic and behavioural characteristics associated with the infection. METHODS: We undertook a cross-sectional survey and syphilis and HIV serologic testing among 11 473 patients attending 14 community and hospital-based dermatovenereal clinics across eight cities in Guangxi between December 2004 and February 2006. RESULTS: 1297 (11.9%) patients demonstrated positive toludine red unheated serum test and Treponema pallidum particle agglutination results with serologic testing. A total of 58% (752) of seropositive subjects presented with a genital ulcer, palmar/plantar rash or inguinal lymphadenopathy. Female sex (OR = 2.23, 95% confidence intervals (CI) = 1.69 to 3.00, p<0.001), less education (middle school, OR = 1.70, 95% CI = 1.11 to 2.62, p = 0.023; primary school or less, OR = 1.98, 95% CI = 1.13 to 3.46, p = 0.017) and high annual income (OR = 1.91, 95% CI = 1.18 to 3.10, p = 0.009 for >30 000 RMB yuan) were associated with serologically positive status. Syphilis infection was significantly more prevalent in city 2 (19.5%, OR = 3.07, 95% CI = 1.83 to 5.16, p<0.001), city 4 (16.6%, OR = 1.90, 95% CI = 1.10 to 3.28, p = 0.011) and city 8 (13.8%, OR = 1.83, 95% CI = 1.13 to 2.97, p = 0.006). A total of 40.1% (532) of infected subjects engaged in commercial sex and increased rates of the infection was associated with multiple sexual partners (OR = 1.54, 95% CI = 1.16 to 2.06, p = 0.003). A total of 1.2% (133) of participants carried laboratory markers for HIV and 1.8% (23) of patients with syphilis were positive for HIV. CONCLUSIONS:Syphilis infection has reached alarming rates in China's STI clinic population, suggesting a generalised spread of the disease through commercial sex and bridging populations. Syphilis control is deserving of China's highest priority. Universal screening for syphilis and HIV testing in STI clinics should be considered as measures for control.
Authors: R H Gray; M J Wawer; R Brookmeyer; N K Sewankambo; D Serwadda; F Wabwire-Mangen; T Lutalo; X Li; T vanCott; T C Quinn Journal: Lancet Date: 2001-04-14 Impact factor: 79.321
Authors: J Heikel; S Sekkat; F Bouqdir; H Rich; B Takourt; F Radouani; N Hda; S Ibrahimy; A Benslimane Journal: Eur J Epidemiol Date: 1999-09 Impact factor: 8.082
Authors: Steven J Reynolds; Arun R Risbud; Mary E Shepherd; Jonathan M Zenilman; Ronald S Brookmeyer; Ramesh S Paranjape; Anand D Divekar; Raman R Gangakhedkar; Manisha V Ghate; Robert C Bollinger; Sanjay M Mehendale Journal: J Infect Dis Date: 2003-04-23 Impact factor: 5.226
Authors: William L Parish; Edward O Laumann; Myron S Cohen; Suiming Pan; Heyi Zheng; Irving Hoffman; Tianfu Wang; Kwai Hang Ng Journal: JAMA Date: 2003-03-12 Impact factor: 56.272
Authors: Rachel V Pearline; Joseph D Tucker; Liu-Feng Yuan; Jin Bu; Yue-Ping Yin; Xiang-Sheng Chen; Myron S Cohen Journal: AIDS Patient Care STDS Date: 2010-06 Impact factor: 5.078
Authors: Susan A Tuddenham; Kathleen R Page; Patrick Chaulk; Erika B Lobe; Khalil G Ghanem Journal: Int J STD AIDS Date: 2016-07-10 Impact factor: 1.359
Authors: Fan Lu; Yujiang Jia; Xinhua Sun; Lan Wang; Wei Liu; Yan Xiao; Gang Zeng; Chunmei Li; Jianbo Liu; Holly Cassell; Huey T Chen; Sten H Vermund Journal: Southeast Asian J Trop Med Public Health Date: 2009-03 Impact factor: 0.267
Authors: Li-Gang Yang; Joseph D Tucker; Feng-Ying Liu; Xu-Qi Ren; Xuan Hong; Cheng Wang; Megan M McLaughlin; Cedric H Bien; Xiang-Sheng Chen; Bin Yang Journal: PLoS One Date: 2013-08-29 Impact factor: 3.240
Authors: Li-Gang Yang; Joseph D Tucker; Bin Yang; Song-Ying Shen; Xi-Feng Sun; Yong-Feng Chen; Xiang-Sheng Chen Journal: BMC Public Health Date: 2010-12-30 Impact factor: 3.295